Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RELA | Q04206 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL622876 | 1.00 | MAOB (0.56) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL2947332 | 1.00 | MAOB (0.56) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL14491222 | 1.00 | MAOB (0.56) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL10539842 | 0.93 | ALDH1A1 (0.64) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL10042632 | 0.93 | ALDH1A1 (0.64) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL9973880 | 0.90 | MAOB (0.70) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL11692031 | 0.90 | MAOB (0.70) | MAOBNFE2L2CYP19A1MAOACYP1B1 | |
| SCHEMBL2577996 | 0.88 | ALDH1A1 (0.61) | CYP1B1ALDH1A1RAB9AHPGDKDM4E | |
| SCHEMBL9679607 | 0.88 | ALDH1A1 (0.61) | CYP1B1ALDH1A1RAB9AHPGDKDM4E | |
| SCHEMBL9679616 | 0.88 | ALDH1A1 (0.61) | CYP1B1ALDH1A1RAB9AHPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735767-A | Method for preparing polyisobutene and block copolymer thereof by Fe system coinitiator | 北京石油化工学院 | 2025-04-01 | — | — | CN | claimed |
| CN-114539079-A | Diamine monomer containing tetraphenylethylene-diarylamine structure, preparation method and application of diamine monomer in super-stable electrochromic material | 吉林大学 | 2022-05-27 | — | — | CN | claimed |
| US-7105714-B2 | Phosphonium salt formation from a phosphine and a carbonium compound, ball milling to form the phosphorus ylide, phosphorylation of an aldehyde or ketone; one pot process; improved catalyst selectivity, efficiency; low temperature, industrial scale | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2006-09-12 | — | — | US | claimed |
| US-20040260128-A1 | Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2004-12-23 | — | — | US | claimed |
| US-20030176740-A1 | Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2003-09-18 | — | — | US | claimed |
| WO-2003066548-A2 | SOLVENT-FREE MECHANOCHEMICAL PREPARATION OF PHOSPHONIUM SALTS, PHOSPHORUS YLIDES, AND OLEFINS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2003-08-14 | — | — | WO | claimed |
| CN-122079722-A | Triphenylamine-mediated isomerization method for photocatalytic olefins E to Z | — | 2026-05-26 | — | — | CN | disclosed |
| CN-119735767-A | Method for preparing polyisobutene and block copolymer thereof by Fe system coinitiator | 北京石油化工学院 | 2025-04-01 | — | — | CN | disclosed |
| CN-119263992-A | Novel compound for capping layer and organic light-emitting element comprising same | 东进世美肯株式会社 | 2025-01-07 | — | — | CN | disclosed |
| CN-119080719-A | Preparation method of polysubstituted olefin epoxy compound | 广西科技大学 | 2024-12-06 | — | — | CN | disclosed |
| US-20240360156-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-10-31 | — | — | US | disclosed |
| US-20240027901-A1 | PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME | SAN-APRO LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-4261214-A1 | PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME | San-Apro Ltd. (JP) | 2023-10-18 | — | — | EP | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0596057-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1994-05-11 | — | — | EP | disclosed |
| WO-1993021183-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1993-10-28 | — | — | WO | disclosed |
| EP-0041043-B1 | PROCESS FOR THE PREPARATION OF DERIVATIVES OF ALKENYL BENZENE OR ALKENYL NAPHTHALENE | CIBA-GEIGY AG (CH) | 1983-11-09 | — | — | EP | disclosed |
| US-4335055-A | Process for the preparation of alkenylbenzene derivatives or alkenylnaphthalene derivatives | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| EP-0041043-A1 | Process for the preparation of derivatives of alkenyl benzene or alkenyl naphthalene | CIBA-GEIGY AG (CH) | 1981-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240360156-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | GRIN1, GRIN2C, GRIN2A | MAOB 258/4885NFE2L2 2918/4885CYP19A1 985/4885 |
| US-20240027901-A1 | PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME | ATIC, MAP1LC3C, TYR | MAOB 1035/4885NFE2L2 2519/4885CYP19A1 3266/4885 |
| US-20040260128-A1 | Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins | CCR4, CCR1, CCR6 | MAOB 4881/4885NFE2L2 4005/4885CYP19A1 4658/4885 |
| US-20030176740-A1 | Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins | CCR4, CCR1, CCR6 | MAOB 4881/4885NFE2L2 4005/4885CYP19A1 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.